MSB 4.52% 95.0¢ mesoblast limited

"Protocol 275 is not an adequate and well-controlled trial and...

  1. 3,929 Posts.
    lightbulb Created with Sketch. 1341
    "Protocol 275 is not an adequate and well-controlled trial and does not provide confirmatory evidence of efficacy to support a license application."

    This is from a briefing document for ODAC. Even if the statement is still valid it doesn't mention that biomarker data is not valid.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
95.0¢
Change
-0.045(4.52%)
Mkt cap ! $1.093B
Open High Low Value Volume
$1.00 $1.01 95.0¢ $1.634M 1.680M

Buyers (Bids)

No. Vol. Price($)
22 281820 95.0¢
 

Sellers (Offers)

Price($) Vol. No.
95.5¢ 97615 49
View Market Depth
Last trade - 14.17pm 20/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.